Keyword Suggestion
Domain Informations
Asceneuron.com lookup results from whois.registrar.internetx.com server:
- Domain created: 2012-05-21T09:30:32Z
- Domain updated: 2025-05-22T07:10:38Z
- Domain expires: 2026-05-21T09:30:32Z 0 Years, 126 Days left
- Website age: 13 Years, 237 Days
- Registrar Domain ID: 1721738840_DOMAIN_COM-VRSN
- Registrar Url: http://www.internetx.com
- Registrar WHOIS Server: whois.registrar.internetx.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +49.94159559480
- Name server:
- NSC1.TOPHOST.CH
- NSC2.TOPHOST.CH
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 194.150.248.33
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
Site Inspections
Port Scanner (IP: 194.150.248.33)
Spam Check (IP: 194.150.248.33)
Email address with asceneuron.com
Recent Searched Sites
› Vendaerp.com.br (0 seconds ago) / US
› Sablonas.lt (1 seconds ago) / LT
› Porngifmag.com (2 seconds ago) / US
› Vb-muensterland.de (0 seconds ago) / DE
› Rowdycafe.com (1 seconds ago) / SG
› Fucho.u-coop.net (0 seconds ago) / SG
› Program-amoris.webnode.sk (2 seconds ago) / DE
› Depomart.com (2 seconds ago) / JP
› Skinradiancespraytans.com (3 seconds ago) / US
› Otpbank.hu (0 seconds ago) / HU
› Signatureaviation.com (0 seconds ago) / US
› Asceneuron.com (0 seconds ago) / CH
› Iota-foundation.org (1 seconds ago) / US
› Johnsoncitytransit.org (6 seconds ago) / US
› Int-ipa.winstondurand.com (1 seconds ago) / US
› Planfortheplanet.org.au (3 seconds ago) / US
› 0349.com (0 seconds ago) / US
› Web-app-pt.mybiogen.io (3 seconds ago) / US
› Chennaitourstravelss.com (1 seconds ago) / US
› Fu-okuyama.jp (5 seconds ago) / JP
Websites Listing
We found Websites Listing below when search with asceneuron.com on Search Engine
Asceneuron Company Profile - Office Locations, Competitors, …
2021-07-28 · Asceneuron is a clinical-stage biotech company focusing on neurodegenerative disorders. It develops orally bioavailable therapeutics for debilitating such disorders as orphan tauopathies, Alzheimer’s, and Parkinson’s disease. The company aims to prevent disease progression in tauopathies and reverse cognitive impairment in dementia. Show more
Craft.coAsceneuron SA Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Asceneuron SA of Lausanne, VAUD. Get the latest business insights from Dun & Bradstreet.
Dnb.comAsceneuron - Sofinnova Partners
Asceneuron researches and develops oral small molecule therapeutics targeting tauopathies for treating progressive supranuclear palsy (PSP), other related neurodegenerative diseases and Alzheimer’s disease. The lead product, an O-GlcNAcase inhibitor that in preclinical studies has been demonstrated to modulate tau pathology, has entered the critical regulatory studies to …
Sofinnovapartners.comRisultati della ricerca per Asceneuron S.A. - Registro degli studi ...
Studi clinici sponsorizzati da Asceneuron S.A. Totale 1 risultati. NCT04759365. Reclutamento. Studio sulla sicurezza, tollerabilità, farmacocinetica e farmacodinamica dell'ASN51 orale in soggetti sani e soggetti con malattia di Alzheimer. Condizioni: Malattia di Alzheimer . Condizioni mediche. COVID-19 ; Vaiolo delle scimmie; 15q13.3 Sindrome da microdelezione; Disturbo …
Ichgcp.netAsceneuron SA | LinkedIn
Asceneuron is a clinical stage biotech company focused on the development of orally bioavailable therapeutics for debilitating neurodegenerative disorders with high unmet medical need.
Linkedin.comAsceneuron S.A. - Company Profiles - BCIQ
For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, BCIQ provides accurate information and context to support profitable and strategic decision making. Unlike other intelligence solutions, BCIQ exclusively supports the unique needs of the …
Profiles.biocentury.comAsceneuron Appoints Prominent Healthcare Leader Catherine …
2021-07-20 · Asceneuron SA, a clinical stage company dedicated to targeting the root cause of neurodegenerative diseases, announced today the appointment of Catherine Moukheibir to its Board of Directors. Catherine is a highly respected healthcare executive with extensive experience over the last 30 years of leadership in finance, capital markets and life sciences.
Pharmiweb.jobsAsceneuron SA (@asceneuron_sa) / Twitter
2021-07-27 · Asceneuron is a clinical stage biotech company focused on the development of orally bioavailable therapeutics for debilitating neurodegenerative disorders
Twitter.comAsceneuron to Provide Update on O-GlcNAcase Pipeline at …
2021-09-30 · Asceneuron SA, a clinical stage company dedicated to targeting the root causes of neurodegenerative diseases such as the intracellular aggregation of the microtubule-associated protein tau, is ...
Finance.yahoo.comAsceneuron | CipherBio
Explore Asceneuron's investment information, scientific platforms, therapeutic approaches, indications and more here! Explore Asceneuron's investment information, scientific platforms, therapeutic approaches, indications and more here! Home. PRO Data. Investor Insights. VC Funds Raised. M&A Insights. IPO Insights . Investors. Lead Investors. Accelerators & …
Cipherbio.comAsceneuron SA | Lausanne, Switzerland | ASCENEURON
Find 3 researchers and browse 1 departments, publications, full-texts, contact details and general information related to Asceneuron SA | Lausanne, Switzerland | ASCENEURON
Researchgate.netResultados da pesquisa para Asceneuron S.A. - Registro de Ensaios ...
Ensaios clínicos patrocinados por Asceneuron S.A. Total de 0 resultados. Nada encontrado. Condições médicas. COVID-19; Varíola dos macacos; Artrogripose; Gastrite Hipertrófica; Hyperferritinemia; Linfangiomioma; Miosarcoma; Neurodermatite; Câncer Induzido por Radiação; SLC35A2-CDG; Neoplasias da glândula salivar ; Hipersensibilidade ao Marisco; Dermatose …
Ichgcp.nethighpoint solutions acquired by iqvia - mstao.net
2022-07-05 · HighPoint Solutions is an IQVIA company. Average salary for IQVIA Senior Talent Acquisition Specialist in Siĕmréab: US$101,802. - Asceneuron se profile face aux maladies de l'alzheimer et de ParkinsonLa société lausannoise, spin-off du groupe Merck Serono, a levé des dizaines de millions de francs pour s'attaquer à ces maladies en ...
Mstao.netVaud Companies With More Than $1M in Revenue
Estimated Revenue Range $1M to $10M. Location Vaud, Switzerland, Europe. CB Rank (Hub) 11,026. Number of Founders 266. Average Founded Date Oct 22, 1994. Percentage Acquired 2%. Percentage of Public Organizations 1%. Percentage Non-Profit 1%. Number of For-Profit Companies 748.
Crunchbase.com2nd BrainFit4Life WebSymposium: Implementation of Global …
2021-11-30 · Futurs étudiants; ÉTUDIANTS; COLLABORATEURS; 2nd BrainFit4Life WebSymposium: Implementation of Global Technologies …
Agenda.unifr.chJP2011500758A5 - - Google Patents
Download PDF Info Publication number JP2011500758A5. JP2011500758A5 JP2010530433A JP2010530433A JP2011500758A5 JP 2011500758 A5 JP2011500758 A5 JP 2011500758A5 JP 2010530433 A JP2010530433 A JP 2010530433A JP 2010530433 A JP2010530433 A JP 2010530433A JP 2011500758 A5 JP2011500758 A5 JP 2011500758A5 Authority JP Japan …
Patents.google.comInhibikase Initiates Early-Stage Study Of Parkinson’s Candidate ...
Related Articles: The road ahead: 2022 January 20, 2022 # # # # The first post at the start of each year on the SoPD website tries to provide an overview of where things are in the search for ‘disease modifying’ therapies for Parkinson’s. It is an exercise in managing expectations as well as discussing what research events are scheduled for the next year so that we can keep…
Parkinson.fit
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| dlxsf.com | networksolutions.com | -3 Years, -234 Days |
| eccafv.org | enom.com | -3 Years, -189 Days |
| cuty.io | godaddy.com | -3 Years, -88 Days |
| tootbuzz.com | godaddy.com | -1 Years, -266 Days |
| lifta20mg.com | maxinames.com | -2 Years, -344 Days |
| jinglebell.com | gandi.net | -3 Years, -129 Days |
| scit.org | networksolutions.com | 330 Days |
| wornstar.com | godaddy.com | 4 Years, 62 Days |
| pmcamd.com | networksolutions.com | -2 Years, -182 Days |
| hedman.com | godaddy.com | -3 Years, -193 Days |
